-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
During -X- _ O
the -X- _ O
early -X- _ O
stages -X- _ O
of -X- _ O
a -X- _ O
new -X- _ O
influenza -X- _ O
pandemic -X- _ O
, -X- _ O
travel -X- _ B-Intervention
restriction -X- _ I-Intervention
is -X- _ O
an -X- _ O
immediate -X- _ O
and -X- _ O
non-pharmaceutical -X- _ O
means -X- _ O
of -X- _ O
retarding -X- _ O
incidence -X- _ O
growth. -X- _ O
It -X- _ O
extends -X- _ O
the -X- _ O
time -X- _ O
frame -X- _ O
of -X- _ O
effective -X- _ O
mitigation -X- _ O
, -X- _ O
especially -X- _ O
when -X- _ O
the -X- _ O
characteristics -X- _ O
of -X- _ O
the -X- _ O
emerging -X- _ O
virus -X- _ O
are -X- _ O
unknown. -X- _ O
In -X- _ O
the -X- _ O
present -X- _ O
study -X- _ O
, -X- _ O
we -X- _ O
used -X- _ O
the -X- _ O
2009 -X- _ B-Patient
influenza -X- _ I-Patient
A -X- _ I-Patient
pandemic -X- _ I-Patient
as -X- _ O
a -X- _ O
case -X- _ O
study -X- _ O
to -X- _ O
evaluate -X- _ O
the -X- _ O
impact -X- _ O
of -X- _ O
regulating -X- _ B-Intervention
air -X- _ I-Intervention
, -X- _ I-Intervention
sea -X- _ I-Intervention
, -X- _ I-Intervention
and -X- _ I-Intervention
land -X- _ I-Intervention
transport. -X- _ I-Intervention
Other -X- _ B-Intervention
government -X- _ I-Intervention
strategies -X- _ I-Intervention
, -X- _ I-Intervention
namely -X- _ I-Intervention
, -X- _ I-Intervention
antivirals -X- _ I-Intervention
and -X- _ I-Intervention
hospitalizations -X- _ I-Intervention
, -X- _ O
were -X- _ O
also -X- _ O
evaluated. -X- _ O
METHODS -X- _ O
: -X- _ O
Hong -X- _ O
Kong -X- _ O
arrivals -X- _ O
from -X- _ O
44 -X- _ O
countries -X- _ O
via -X- _ O
air -X- _ O
, -X- _ O
sea -X- _ O
, -X- _ O
and -X- _ O
land -X- _ O
transports -X- _ O
were -X- _ O
imported -X- _ O
into -X- _ O
a -X- _ O
discrete -X- _ O
stochastic -X- _ O
Susceptible -X- _ O
, -X- _ O
Exposed -X- _ O
, -X- _ O
Infectious -X- _ O
and -X- _ O
Recovered -X- _ O
( -X- _ O
SEIR -X- _ O
) -X- _ O
host-flow -X- _ O
model. -X- _ O
The -X- _ O
model -X- _ O
allowed -X- _ O
a -X- _ O
number -X- _ O
of -X- _ O
latent -X- _ O
and -X- _ O
infectious -X- _ O
cases -X- _ O
to -X- _ O
pass -X- _ O
the -X- _ O
border -X- _ O
, -X- _ O
which -X- _ O
constitutes -X- _ O
a -X- _ O
source -X- _ O
of -X- _ O
local -X- _ O
disease -X- _ O
transmission. -X- _ O
We -X- _ O
also -X- _ O
modeled -X- _ O
antiviral -X- _ B-Intervention
and -X- _ I-Intervention
hospitalization -X- _ I-Intervention
prevention -X- _ I-Intervention
strategies -X- _ I-Intervention
to -X- _ O
compare -X- _ O
the -X- _ O
effectiveness -X- _ O
of -X- _ O
these -X- _ O
control -X- _ O
measures. -X- _ O
Baseline -X- _ O
reproduction -X- _ O
rate -X- _ O
was -X- _ O
estimated -X- _ O
from -X- _ O
routine -X- _ O
surveillance -X- _ O
data. -X- _ O
RESULTS -X- _ O
: -X- _ O
Regarding -X- _ B-Outcome
air -X- _ I-Outcome
travel -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
main -X- _ I-Outcome
route -X- _ I-Outcome
connected -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
influenza -X- _ I-Outcome
source -X- _ I-Outcome
area -X- _ I-Outcome
should -X- _ I-Outcome
be -X- _ I-Outcome
targeted -X- _ I-Outcome
for -X- _ I-Outcome
travel -X- _ I-Outcome
restrictions -X- _ I-Outcome
; -X- _ I-Outcome
imposing -X- _ I-Outcome
a -X- _ I-Outcome
99 -X- _ I-Outcome
% -X- _ I-Outcome
air -X- _ I-Outcome
travel -X- _ I-Outcome
restriction -X- _ I-Outcome
delayed -X- _ I-Outcome
the -X- _ I-Outcome
epidemic -X- _ I-Outcome
peak -X- _ I-Outcome
by -X- _ I-Outcome
up -X- _ I-Outcome
to -X- _ I-Outcome
two -X- _ I-Outcome
weeks. -X- _ I-Outcome
Once -X- _ I-Outcome
the -X- _ I-Outcome
pandemic -X- _ I-Outcome
was -X- _ I-Outcome
established -X- _ I-Outcome
in -X- _ I-Outcome
China -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
strong -X- _ I-Outcome
land -X- _ I-Outcome
connection -X- _ I-Outcome
between -X- _ I-Outcome
Hong -X- _ I-Outcome
Kong -X- _ I-Outcome
and -X- _ I-Outcome
China -X- _ I-Outcome
rendered -X- _ I-Outcome
Hong -X- _ I-Outcome
Kong -X- _ I-Outcome
vulnerable. -X- _ I-Outcome
Antivirals -X- _ I-Outcome
and -X- _ I-Outcome
hospitalization -X- _ I-Outcome
were -X- _ I-Outcome
found -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
more -X- _ I-Outcome
effective -X- _ I-Outcome
on -X- _ I-Outcome
attack -X- _ I-Outcome
rate -X- _ I-Outcome
reductions -X- _ I-Outcome
than -X- _ I-Outcome
travel -X- _ I-Outcome
restrictions. -X- _ I-Outcome
Combined -X- _ I-Outcome
strategies -X- _ I-Outcome
( -X- _ I-Outcome
with -X- _ I-Outcome
99 -X- _ I-Outcome
% -X- _ I-Outcome
restriction -X- _ I-Outcome
on -X- _ I-Outcome
all -X- _ I-Outcome
transport -X- _ I-Outcome
modes -X- _ I-Outcome
) -X- _ I-Outcome
deferred -X- _ I-Outcome
the -X- _ I-Outcome
peak -X- _ I-Outcome
for -X- _ I-Outcome
long -X- _ I-Outcome
enough -X- _ I-Outcome
to -X- _ I-Outcome
establish -X- _ I-Outcome
a -X- _ I-Outcome
vaccination -X- _ I-Outcome
program. -X- _ I-Outcome
CONCLUSION -X- _ O
: -X- _ O
The -X- _ O
findings -X- _ O
will -X- _ O
assist -X- _ O
policy-makers -X- _ O
with -X- _ O
decisions -X- _ O
on -X- _ O
handling -X- _ O
similar -X- _ O
future -X- _ O
pandemics. -X- _ O
We -X- _ O
also -X- _ O
suggest -X- _ O
regulating -X- _ O
the -X- _ O
extent -X- _ O
of -X- _ O
restriction -X- _ O
and -X- _ O
the -X- _ O
transport -X- _ O
mode -X- _ O
, -X- _ O
once -X- _ O
restriction -X- _ O
has -X- _ O
been -X- _ O
deemed -X- _ O
necessary -X- _ O
for -X- _ O
pandemic -X- _ O
control. -X- _ O
Although -X- _ O
travel -X- _ O
restrictions -X- _ O
have -X- _ O
yet -X- _ O
to -X- _ O
gain -X- _ O
social -X- _ O
acceptance -X- _ O
, -X- _ O
they -X- _ O
allow -X- _ O
time -X- _ O
for -X- _ O
mitigation -X- _ O
response -X- _ O
when -X- _ O
a -X- _ O
new -X- _ O
and -X- _ O
highly -X- _ O
intrusive -X- _ O
virus -X- _ O
emerges -X- _ O
. -X- _ O

